Elizabeth M. Kang

5.7k total citations
82 papers, 2.8k citations indexed

About

Elizabeth M. Kang is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Elizabeth M. Kang has authored 82 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 25 papers in Genetics and 24 papers in Molecular Biology. Recurrent topics in Elizabeth M. Kang's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (18 papers), Virus-based gene therapy research (16 papers) and Hematopoietic Stem Cell Transplantation (15 papers). Elizabeth M. Kang is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (18 papers), Virus-based gene therapy research (16 papers) and Hematopoietic Stem Cell Transplantation (15 papers). Elizabeth M. Kang collaborates with scholars based in United States, Germany and Italy. Elizabeth M. Kang's co-authors include Harry L. Malech, John F. Tisdale, Hongxiang Hui, Corine Bertolotto, Umberto Di Mario, Angela Bulotta, Loredana Farilla, Riccardo Perfetti, Matthew M. Hsieh and Richard Childs and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Elizabeth M. Kang

80 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth M. Kang United States	28	862	686	663	545	473	82	2.8k
Christie P. Thomas United States	31	1.2k 1.4×	272 0.4×	755 1.1×	300 0.6×	319 0.7×	130	2.9k
Willem A. Dik Netherlands	33	914 1.1×	280 0.4×	1.1k 1.6×	396 0.7×	647 1.4×	183	4.2k
Jerry Stein Israel	27	460 0.5×	340 0.5×	547 0.8×	793 1.5×	282 0.6×	119	2.3k
D. P. Singal Canada	30	508 0.6×	625 0.9×	1.4k 2.0×	561 1.0×	615 1.3×	119	3.4k
Bernard Charpentier France	40	804 0.9×	278 0.4×	1.5k 2.2×	370 0.7×	1.6k 3.3×	106	5.6k
Violet Esquenazi United States	32	272 0.3×	401 0.6×	735 1.1×	377 0.7×	1.6k 3.4×	153	3.5k
Paul Martin United States	27	365 0.4×	176 0.3×	279 0.4×	985 1.8×	469 1.0×	109	3.1k
Hubert Nivet France	28	581 0.7×	259 0.4×	890 1.3×	439 0.8×	345 0.7×	99	3.1k
Neal S. Rote United States	39	753 0.9×	307 0.4×	1.2k 1.8×	640 1.2×	186 0.4×	113	4.1k
R. Margreiter Austria	35	764 0.9×	361 0.5×	311 0.5×	158 0.3×	1.5k 3.2×	215	4.1k

Countries citing papers authored by Elizabeth M. Kang

Since Specialization

Citations

This map shows the geographic impact of Elizabeth M. Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth M. Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth M. Kang more than expected).

Fields of papers citing papers by Elizabeth M. Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth M. Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth M. Kang. The network helps show where Elizabeth M. Kang may publish in the future.

Co-authorship network of co-authors of Elizabeth M. Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth M. Kang. A scholar is included among the top collaborators of Elizabeth M. Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth M. Kang. Elizabeth M. Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Williams, Eleri, Michael H. Albert, Fabian Hauck, et al.. (2023). Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease Carriers. Journal of Clinical Immunology. 43(8). 1964–1973. 4 indexed citations

Burdorf, Lars, Zhuo Gao, Andrea N. Riner, et al.. (2023). Expression of human thrombomodulin by GalTKO.hCD46 pigs modulates coagulation cascade activation by endothelial cells and during ex vivo lung perfusion with human blood. Xenotransplantation. 30(6). e12828–e12828. 3 indexed citations

Parta, Mark, Jennifer Cuellar‐Rodríguez, Juan Gea‐Banacloche, et al.. (2022). Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease. Transplant Infectious Disease. 24(2). e13815–e13815. 1 indexed citations

Vetharoy, Winston, Uimook Choi, Christine Rivat, et al.. (2021). Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47 ^phox -Deficient Chronic Granulomatous Disease. Human Gene Therapy. 32(17-18). 949–958. 4 indexed citations

Wilder, Jennifer, Sharon Adams, Joie Davis, et al.. (2019). Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(8). 1666–1673. 8 indexed citations

Jones, Karlie, Jian Luo, Patricia Kiesler, et al.. (2018). Recombinant Pregnancy-Specific Glycoprotein 1 Has a Protective Role in a Murine Model of Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 25(2). 193–203. 12 indexed citations

Jones, Karlie, Uimook Choi, Ji‐Liang Gao, et al.. (2017). A Novel Method for Screening Adenosine Receptor Specific Agonists for Use in Adenosine Drug Development. Scientific Reports. 7(1). 44816–44816. 12 indexed citations

Merling, Randall K., Douglas B. Kuhns, Colin L. Sweeney, et al.. (2016). Gene-edited pseudogene resurrection corrects p47phox-deficient chronic granulomatous disease. Blood Advances. 1(4). 270–278. 39 indexed citations

Kang, Elizabeth M., Mark Parta, Dianne Hilligoss, et al.. (2016). Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High Risk Chronic Granulomatous Disease (CGD) Patients. Biology of Blood and Marrow Transplantation. 22(3). S327–S328. 1 indexed citations

10.

Walter, Jolán E., Karin Chen, Roshini S. Abraham, et al.. (2016). Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG Deficiency. Journal of Clinical Immunology. 36(7). 725–732. 12 indexed citations

11.

Parta, Mark, Dianne Hilligoss, Corin Kelly, et al.. (2015). Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report. Journal of Clinical Immunology. 35(7). 675–680. 26 indexed citations

12.

Panch, Sandhya R., Yu Ying Yau, Elizabeth M. Kang, et al.. (2014). Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiency. Transfusion. 55(2). 265–274. 5 indexed citations

13.

Theobald, Narda, et al.. (2010). Successful Control of Preexistent Active Infection by Granulocyte Transfusions During Conditioning Induced Cytopenia In Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Stem Cell Transplant. Blood. 116(21). 1329–1329. 3 indexed citations

14.

Vlachos, Adrianna, Sarah E. Ball, Niklas Dahl, et al.. (2008). Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. British Journal of Haematology. 142(6). 859–876. 297 indexed citations

15.

Kang, Elizabeth M. & Harry L. Malech. (2008). Advances in treatment for chronic granulomatous disease. Immunologic Research. 43(1-3). 77–84. 31 indexed citations

16.

Kang, Elizabeth M., Matthew M. Hsieh, Mark E. Metzger, et al.. (2006). Busulfan pharmacokinetics, toxicity, and low-dose conditioning for autologous transplantation of genetically modified hematopoietic stem cells in the rhesus macaque model. Experimental Hematology. 34(2). 132–139. 26 indexed citations

17.

Brenner, Sebastian, Martin Ryser, Uimook Choi, et al.. (2006). Polyclonal Long-Term MFGS-gp91phox Marking in Rhesus Macaques after Nonmyeloablative Transplantation with Transduced Autologous Peripheral Blood Progenitor Cells. Molecular Therapy. 14(2). 202–211. 8 indexed citations

18.

Kang, Elizabeth M., Philipp Zickler, Sean Burns, et al.. (2005). Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is established. Experimental Hematology. 33(6). 699–705. 47 indexed citations

19.

Gao, Chunji, Elizabeth M. Kang, Ken Kuramoto, et al.. (2003). Retrovirally transduced muscle-derived cells contribute to hematopoiesis at very low levels in the nonhuman primate model. Molecular Therapy. 8(6). 974–980. 4 indexed citations

20.

Kang, Elizabeth M., Moniek de Witte, Harry L. Malech, et al.. (2002). Gene Therapy–based Treatment for HIV-Positive Patients with Malignancies. Journal of Hematotherapy & Stem Cell Research. 11(5). 809–816. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact